These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29698332)

  • 1. Serum Proteomics in African American Female Patients With Irritable Bowel Syndrome: An Exploratory Study.
    Weaver KR; Melkus GE; Fletcher J; Henderson WA
    Nurs Res; 2018; 67(3):261-267. PubMed ID: 29698332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of serum proteome signature of irritable bowel syndrome: Potential utility of the tool for early diagnosis and patient's stratification.
    Tsigaridas A; Anagnostopoulos AK; Papadopoulou A; Ioakeim S; Vaiopoulou A; Papanikolaou IS; Viazis N; Karamanolis G; Mantzaris GJ; Tsangaris GT; Gazouli M
    J Proteomics; 2018 Sep; 188():167-172. PubMed ID: 28757466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.
    Goo YA; Cain K; Jarrett M; Smith L; Voss J; Tolentino E; Tsuji J; Tsai YS; Panchaud A; Goodlett DR; Shulman RJ; Heitkemper M
    J Proteome Res; 2012 Dec; 11(12):5650-62. PubMed ID: 22998556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Food-Specific Serum IgG Reactivity in Major Depressive Disorder Patients, Irritable Bowel Syndrome Patients and Healthy Controls.
    Karakula-Juchnowicz H; Gałęcka M; Rog J; Bartnicka A; Łukaszewicz Z; Krukow P; Morylowska-Topolska J; Skonieczna-Zydecka K; Krajka T; Jonak K; Juchnowicz D
    Nutrients; 2018 Apr; 10(5):. PubMed ID: 29710769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Tryptophan Metabolite Levels During Sleep in Patients With and Without Irritable Bowel Syndrome (IBS).
    Heitkemper MM; Han CJ; Jarrett ME; Gu H; Djukovic D; Shulman RJ; Raftery D; Henderson WA; Cain KC
    Biol Res Nurs; 2016 Mar; 18(2):193-8. PubMed ID: 26156003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.
    Hod K; Ringel-Kulka T; Martin CF; Maharshak N; Ringel Y
    J Clin Gastroenterol; 2016 Mar; 50(3):227-32. PubMed ID: 25930973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High risk of temporomandibular disorder in irritable bowel syndrome: Is there a correlation with greater illness severity?
    Gallotta S; Bruno V; Catapano S; Mobilio N; Ciacci C; Iovino P
    World J Gastroenterol; 2017 Jan; 23(1):103-109. PubMed ID: 28104985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel biomarker panel for irritable bowel syndrome and the application in the general population.
    Mujagic Z; Tigchelaar EF; Zhernakova A; Ludwig T; Ramiro-Garcia J; Baranska A; Swertz MA; Masclee AA; Wijmenga C; van Schooten FJ; Smolinska A; Jonkers DM
    Sci Rep; 2016 Jun; 6():26420. PubMed ID: 27263852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal-enriched extracellular vesicles in individuals with IBS: A pilot study of COMT and BDNF.
    Weaver KR; Mustapic M; Kapogiannis D; Henderson WA
    Neurogastroenterol Motil; 2022 Jan; 34(1):e14257. PubMed ID: 34499398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex Hormones, BDNF, Leptin, and TGF-β1 in Females With IBS: A Pilot Investigation.
    Weaver KR; Boulineaux CM; Robinson JM; Butler K; Heitkemper MM; Henderson WA
    Biol Res Nurs; 2021 Apr; 23(2):231-237. PubMed ID: 32806924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease signaling through protease activated receptor 1 mediate nerve activation by mucosal supernatants from irritable bowel syndrome but not from ulcerative colitis patients.
    Buhner S; Hahne H; Hartwig K; Li Q; Vignali S; Ostertag D; Meng C; Hörmannsperger G; Braak B; Pehl C; Frieling T; Barbara G; De Giorgio R; Demir IE; Ceyhan GO; Zeller F; Boeckxstaens G; Haller D; Kuster B; Schemann M
    PLoS One; 2018; 13(3):e0193943. PubMed ID: 29529042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study.
    Linsalata M; Riezzo G; D'Attoma B; Clemente C; Orlando A; Russo F
    BMC Gastroenterol; 2018 Nov; 18(1):167. PubMed ID: 30400824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of high-sensitivity CRP as a marker of micro-inflammation in irritable bowel syndrome.
    Hod K; Dickman R; Sperber A; Melamed S; Dekel R; Ron Y; Halpern Z; Berliner S; Maharshak N
    Neurogastroenterol Motil; 2011 Dec; 23(12):1105-10. PubMed ID: 21951717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum zonulin is elevated in IBS and correlates with stool frequency in IBS-D.
    Singh P; Silvester J; Chen X; Xu H; Sawhney V; Rangan V; Iturrino J; Nee J; Duerksen DR; Lembo A
    United European Gastroenterol J; 2019 Jun; 7(5):709-715. PubMed ID: 31210949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMT proteomics analysis of intestinal tissue from patients of irritable bowel syndrome with diarrhea: Implications for multiple nutrient ingestion abnormality.
    Chai YN; Qin J; Li YL; Tong YL; Liu GH; Wang XR; Liu CY; Peng MH; Qin CZ; Xing YR
    J Proteomics; 2021 Jan; 231():103995. PubMed ID: 33011346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum immune biomarkers in irritable bowel syndrome.
    Seyedmirzaee S; Hayatbakhsh MM; Ahmadi B; Baniasadi N; Bagheri Rafsanjani AM; Nikpoor AR; Mohammadi M
    Clin Res Hepatol Gastroenterol; 2016 Nov; 40(5):631-637. PubMed ID: 26850360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Anti-vinculin and Anti-cytolethal Distending Toxin B Antibodies in Subtypes of Irritable Bowel Syndrome.
    Rezaie A; Park SC; Morales W; Marsh E; Lembo A; Kim JH; Weitsman S; Chua KS; Barlow GM; Pimentel M
    Dig Dis Sci; 2017 Jun; 62(6):1480-1485. PubMed ID: 28451914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum resolvin D1 levels as a marker of inflammation in constipation dominant irritable bowel syndrome.
    Karatay E; Utku ÖG
    Turk J Gastroenterol; 2020 Feb; 31(2):113-119. PubMed ID: 32141819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cholinesterase activity is elevated in female diarrhea-predominant irritable bowel syndrome patients compared to matched controls.
    Hod K; Sperber AD; Maharshak N; Ron Y; Shapira I; David Z; Rogowski O; Berliner S; Shenhar-Tsarfaty S; Dekel R
    Neurogastroenterol Motil; 2018 Dec; 30(12):e13464. PubMed ID: 30240124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High interdigestive and postprandial motilin levels in patients with the irritable bowel syndrome.
    Simrén M; Björnsson ES; Abrahamsson H
    Neurogastroenterol Motil; 2005 Feb; 17(1):51-7. PubMed ID: 15670264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.